GROUP ONE TRADING, L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U908. A total of 5 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$7,866,000
+635.1%
115,500
+244.8%
0.02%
+650.0%
Q2 2022$1,070,000
-33.6%
33,500
-28.0%
0.00%0.0%
Q1 2022$1,611,000
+18.1%
46,500
-0.2%
0.00%
+100.0%
Q4 2021$1,364,000
+24.5%
46,600
+8.4%
0.00%0.0%
Q3 2021$1,096,000
-59.3%
43,000
-44.1%
0.00%
-66.7%
Q2 2021$2,693,000
+27.8%
76,900
+48.7%
0.00%0.0%
Q1 2021$2,107,000
-30.3%
51,700
-25.9%
0.00%
-40.0%
Q4 2020$3,023,000
+34.7%
69,800
+71.5%
0.01%
-28.6%
Q3 2020$2,244,000
+2.1%
40,700
+17.0%
0.01%
-30.0%
Q2 2020$2,197,000
-29.2%
34,800
-42.7%
0.01%
-60.0%
Q1 2020$3,101,000
-81.9%
60,700
-71.9%
0.02%
-78.6%
Q4 2019$17,162,000
+110.2%
215,900
+28.3%
0.12%
+77.3%
Q3 2019$8,166,000
+74.0%
168,300
+88.7%
0.07%
+57.1%
Q2 2019$4,692,000
-3.7%
89,200
-3.0%
0.04%
-22.2%
Q1 2019$4,870,000
+192.8%
92,000
+127.2%
0.05%
+285.7%
Q4 2018$1,663,000
-64.8%
40,500
-67.4%
0.01%
-62.2%
Q3 2018$4,727,000
-49.0%
124,400
-39.4%
0.04%
-53.2%
Q2 2018$9,275,000
+261.6%
205,200
+286.4%
0.08%
+203.8%
Q1 2018$2,565,000
+79.1%
53,100
+45.9%
0.03%
+160.0%
Q4 2017$1,432,000
+418.8%
36,400
+309.0%
0.01%
+233.3%
Q3 2017$276,000
-21.8%
8,900
-31.0%
0.00%
-25.0%
Q2 2017$353,000
-69.3%
12,900
-58.7%
0.00%
-69.2%
Q1 2017$1,150,000
+8114.3%
31,200
+3020.0%
0.01%
Q4 2016$14,000
-87.6%
1,000
-79.6%
0.00%
-100.0%
Q3 2016$113,000
-8.1%
4,900
-33.8%
0.00%0.0%
Q2 2016$123,000
+4000.0%
7,400
+3600.0%
0.00%
Q1 2016$3,0002000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,312$4,986,0000.64%
BOOTHBAY FUND MANAGEMENT, LLC 228$866,0000.09%
GROUP ONE TRADING, L.P. 124,400$4,727,0000.04%
SIMPLEX TRADING, LLC 421$1,599,0000.01%
JPMORGAN CHASE & CO 149,900$5,696,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders